Reaction

Antiphospholipid Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,579 reports · 22 co-occurring drugs

As of the last recalculation, Antiphospholipid Syndrome appears in 1,579 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is ROMIPLOSTIM (PRR 29.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Romiplostim3329.529.6
Eltrombopag Olamine4224.624.7
Etonogestrel And Ethinyl Estradiol3923.723.8
Minocycline1517.117.1
Belimumab3715.815.8
Hydroxychloroquine7714.214.3
Norepinephrine1113.713.7
Dalteparin Sodium911.311.3
Warfarin10111.111.1
Norepinephrine Bitartrate1211.111.1
Terbinafine Hydrochloride710.410.4
Voriconazole Injection1710.410.4
Enoxaparin Sodium399.19.1
Warfarin Sodium298.48.4
Eculizumab338.28.2
Voriconazole187.97.9
Apixaban367.27.2
Rivaroxaban1057.17.1
Pitavastatin Calcium56.56.5
Calcium, Magnesium, Potassium, And Sodium Oxybates46.16.1
Remdesivir44.04.0
Drospirenone And Ethinyl Estradiol133.93.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.